# Johnson Zhang

> Johnson Zhang is the Singapore-based founder and Global CEO of Virtue Diagnostics. He founded Xinbo in 2000, joined PerkinElmer after its 2009 acquisition of the business, and subsequently led its Asia-Pacific division. His later venture, Virtue Diagnostics, has expanded through fundraising, partnerships, the acquisition of Brazil’s Labtest and manufacturing operations in Indonesia.

- **Role:** Founder and Global Chief Executive Officer at Virtue Diagnostics
- **Organizations:** Virtue Diagnostics, PerkinElmer, Shanghai Xinbo Biotechnology, Labtest
- **Education:** Bachelor’s degree in mathematics, Fudan University, Master of Business Administration, China Europe International Business School (CEIBS)
- **Known for:** Founded Xinbo and subsequently joined its acquirer, PerkinElmer, as a regional executive., Led Virtue Diagnostics through its US$100 million Series B announcement in January 2022., Expanded Virtue through the 2022 Labtest acquisition and manufacturing operations in Indonesia.

## Career timeline

- **2000** — Founded Xinbo; served as chairman and general manager.
- **2009** — Joined PerkinElmer following its September acquisition of Shanghai Xinbo Biotechnology; appointed to an Asia-Pacific leadership role in October.
- **2010** — Became Vice President of Emerging Diagnostics and General Manager of Asia Pacific at PerkinElmer.
- **2011** — Became Vice President of the Diagnostics Division and General Manager of Asia Pacific at PerkinElmer.
- **2018** — Spoke at CABA’s Boston BioForum on entrepreneurship, acquisitions and cross-border investment.
- **2019** — Virtue Diagnostics founded; Zhang is identified as founder and CEO.
- **2022** — Virtue announced a US$100 million Series B in January and acquired Brazil’s Labtest that year.
- **2023** — Virtue signed a global exclusive distribution agreement with Revvity on December 13.
- **2024** — Virtue’s Cikarang manufacturing facility opened on March 5.
- **2026** — Participated in an August 7 industrial symposium and press conference in Jakarta.

## Achievements

- Founded Xinbo and subsequently joined its acquirer, PerkinElmer, as a regional executive.
- Led Virtue Diagnostics through its US$100 million Series B announcement in January 2022.
- Expanded Virtue through the 2022 Labtest acquisition and manufacturing operations in Indonesia.
- Described growth of PerkinElmer’s regional business from approximately US$10 million to US$400 million during his management period; this is a reported career account.

## Latest updates

- **2026-08** — Spoke at an industrial symposium and press conference in Jakarta about local manufacturing and long-term investment in Indonesia.
- **2025-09** — Visited Brazil for a congress and strategic meetings with Labtest, as described in Labtest’s December 2025 profile.

## Links

- LinkedIn: https://sg.linkedin.com/in/johnson-zhang-8aa77330

---

Profile page: https://yespress.io/johnson-zhang
Published by YesPress — https://yespress.io
Last updated: 2026-10-20